Pharmaceuticals market research reports by GlobalData

• AstraZeneca Plc - Digital Transformation Strategies

  Oct 18, 2023  |  Published by: GlobalData  |  USD 1,495

  AstraZeneca Plc - Digital Transformation Strategies Summary This report provides insight into AstraZeneca's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts. AstraZeneca Plc (A ... Read More

• Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w ... Read More

• Maruho Co Ltd - Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Maruho Co Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic ... Read More

• Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc ... Read More

• Isagenix International LLC - Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Isagenix International LLC - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc ... Read More

• Eisai Inc - Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Eisai Inc - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. ... Read More

• Helix BioMedix Inc (HXBM) - Financial and Strategic SWOT Analysis Review

  Oct 18, 2023  |  Published by: GlobalData  |  USD 125

  Helix BioMedix Inc (HXBM) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness ... Read More

• Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 15, 2023  |  Published by: GlobalData  |  USD 3,495

  Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MLD therapeutics. More than 5,500 diagnosed prevalent cases of MLD are anticipa ... Read More

• Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Mexico Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Reversible Contraceptive Procedures. The databook report ... Read More

• Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Russia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Reversible Contraceptive Procedures. The databook report ... Read More

• Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Reversible Contraceptive Procedures. The databook report pro ... Read More

• South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “South Korea Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Reversible Contraceptive Procedures. The d ... Read More

• Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Canada Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada Reversible Contraceptive Procedures. The databook report ... Read More

• Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Spain Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Reversible Contraceptive Procedures. The databook report pro ... Read More

• China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “China Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Reversible Contraceptive Procedures. The databook report pro ... Read More

• Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Brazil Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil Reversible Contraceptive Procedures. The databook report ... Read More

• India Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  India Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More

• Japan Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  Japan Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More

• Australia Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  Australia Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Neurology Procedures. The databook report provides procedure volumes within se ... Read More

• Italy Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Italy Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Italy Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Italy Reversible Contraceptive Procedures. The databook report pro ... Read More

• Australia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Australia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Reversible Contraceptive Procedures. The databoo ... Read More

• India Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  India Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Reversible Contraceptive Procedures. The databook report pro ... Read More

• Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032

  Oct 12, 2023  |  Published by: GlobalData  |  USD 10,995

  Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Heart Failure (HF) market through 2032. Gl ... Read More

• Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 09, 2023  |  Published by: GlobalData  |  USD 3,495

  Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ARF therapeutics. More than 18 million incident cases of ARF are anticipated in 2023 in ... Read More

• Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 09, 2023  |  Published by: GlobalData  |  USD 3,495

  Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DS therapeutics. More than 123,000 diagnosed prevalent cases of DS are anticipated in 2023 in ... Read More

< prev 20 21 22 23 24 25 26 27 28 29 next >